Oncolytics Biotech Inc ONCY

PR and Partnership

[Investor5876]

ONC's latest press release is impressive. 

Unlike many of ONC's past PR's, this one is very clearly written and unambiguous. 

It is also encouraging. And the promise comes from achievable honest milestones (very different from what we have seen in recent years).

The only outstanding question is financing. ONC does not currently have the funds. 

I believe ONC is within weeks of announcing a major partnership. Three reasons for this:

1. The BC data are compelling enough for a major pharma to make a move. 

2. Even with a reverse split and large capital raise, ONC will not be able to sufficiently finance a 180 patient tiral. 

3. ONC is well aware they do not have the in house capabilities to proceed with a large registration enabling trial. 

Best of luck. IMO This is an excellent entry point for any investor new to the story.

[Investor5876]

One cautionary note is to watch the volume. Under two million shares per day (on no material news) can be reasonably attriuted to increased interest from retail and some additional institutional buying.  Unfortunately, ONCY has a history of spiked trading volumes (over five million) with no material news. That kind of activity is suspicious and has been followed by capital raises at

[canadafan]

They isued materialnews you obviously cant read

[jh1970]

Program & sponsors - IOVC2024 Intravenous Pelareorep Combined with the PD-L1 Inhibitor Atezolizumab Demonstrates Promising Efficacy in Pancreatic and Anal Cancer in the Phase 1/2 GOBLET Study (by Thomas Heinemans) monday October 28th - 9:30 - !0:30